1. |
Sharma VK, Ng KW, Venketasubramanian N, et al. Current status of intravenous thrombolysis for acute ischemic stroke in Asia. Int J Stroke, 2011, 6(6): 523-530.
|
2. |
陈清棠, 贺茂林, 徐忠宝, 等. 急性脑梗死(6 h 以内)静脉溶栓治疗. 中风与神经疾病杂志, 2001, 18(5): 259-261.
|
3. |
国家“九五”攻关课题协作组. 急性脑梗死六小时以内的静脉溶栓治疗. 中华神经科杂志, 2002, 35(4): 210-213.
|
4. |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018. 中华神经科杂志, 2018, 51(9): 666-682.
|
5. |
Fischer U, Arnold M, Nedeltchev K, et al. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke, 2005, 36(10): 2121-2125.
|
6. |
Savitz SI, Lew R, Bluhmki E, et al. Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials. Stroke, 2008, 38(12): 3205-3212.
|
7. |
张文超, 孙昭胜, 刘洪博. 3 种认知功能障碍评定量表在中、重型颅脑损伤后患者 120 例的应用研究. 重庆医学, 2013, 42(9): 988-989.
|
8. |
Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet, 2007, 369(9558): 275-282.
|
9. |
国家统计局. 中国统计年鉴. 北京: 中国统计出版社, 2019: 83-84.
|
10. |
Benedict CR, Refino CJ, Keyt BA, et al. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA. Circulation, 1995, 92(10): 3032-3040.
|
11. |
Parsons M, Spratt N, Bivard A, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med, 2012, 366(12): 1099-1107.
|
12. |
楼敏, 王伊龙, 李子孝, 等. 中国卒中中心建设指南. 中国卒中杂志, 2015, 10(6): 499-507.
|
13. |
Yang FC, Lin CC, Hsueh CJ, et al. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan. Ann Vasc Surg, 2010, 24: 1117-1124.
|
14. |
Teng Y, Jin H, Nan D, et al. In vivo evaluation of urokinase-loaded hollow nanogels for sonothrombolysis on suture embolization-induced acute ischemic stroke rat model. Bioact Mater, 2018, 3(1): 102-109.
|
15. |
Merino P, Diaz A, Yepes M. Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) promote neurorepair in the ischemic brain. Receptors Clin Investig, 2017, 4(2): e1552.201.
|
16. |
Akutagawa N, Sadashima S, Nakagaki H, et al. Intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator (rt-PA) therapy for acute cerebral infarction in a patient with ANCA-associated vasculitis. Rinsho Shinkeigaku, 2017, 57(8): 454-456.
|
17. |
Onatsu J, Taina M, Mustonen P, et al. Soluble urokinase-type plasminogen activator receptor predicts all-cause 5-year mortality in ischemic stroke and TIA. In Vivo, 2017, 31(3): 381-386.
|
18. |
Simats A, Garce ıa-Berrocoso T, Montaner J. Neuroinflammatory biomarkers: from stroke diagnosis and prognosis to therapy. Biochim Biophys Acta, 2016, 1862: 411-424.
|
19. |
王金标. 急诊阿替普酶静脉溶栓治疗急性脑梗死的效果探讨. 中国现代药物应用, 2020, 14(12): 120-122.
|
20. |
Dong Q, Dong Y, Liu L, et al. The Chinese stroke association scientific statement: intravenous thrombolysis in acute ischaemic stroke. Stroke Vasc Neurol, 2017, 2(3): 147-159.
|